(redirected from AHF.)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia.


An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

West's Encyclopedia of American Law, edition 2. Copyright 2008 The Gale Group, Inc. All rights reserved.


n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

Copyright © 1981-2005 by Gerald N. Hill and Kathleen T. Hill. All Right reserved.


1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.
2 an institution to whom a company assigns its book debts (see FACTORING).
3 in Scotland a landlord or superior's agent.
Collins Dictionary of Law © W.J. Stewart, 2006
References in periodicals archive ?
Less than half of the AHF patients were given oral diuretics after surviving from the indexed AHF. For evidence based medications, only 28.67%, 39.91%, and 32.63% of the patients were treated with ACEIs/ARBs, beta-blockers, and spironolactone during the follow-up periods.{Table 5}
At 12-month follow-up, one in two patients were rehospitalized for AHF. At three months mortality had doubled to 15.7%, and reached 26.4% at one-year post discharge.
It is a whole set of resources which can be accessible after becoming a member of FIH and AHF.
Budget 2010 stipulated that $199 million was being allotted to address the legacy of residential schools, yet none was to be committed to the AHF. Half has gone to Health Canada's First Nations and Inuit Health Branch, and half to the Indian Residential Schools Settlement Agreement (IRSSA).
This prospective study examined the value of MPO for diagnosis and risk stratification in AHF. We report 2 major findings.
They symbolized confidence in community-based knowledge that was at the core of healing approaches supported by the AHF.
The combined total of basophilic and/or clear cell LFCA and ADs was greater than the number of basophilic and/or clear cell AHF, indicating a faster growth rate of these AHF compared to eosinophilic AHF. This was consistent with the study of Stauber and Bull (1997), which treated male B6C3[F.sub.1] mice with 2 g/L DCA for 38 or 50 weeks before transferring groups to 0 to 2 g/L DCA for another 2 weeks.